EUVIMEDEUVIMED entdecken
Open Access

Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2

Abigail L Brewer, Claire E Felter, Anna R Sternitzky, Sade M Spencer

Pharmacology Biochemistry and Behavior · 2024

DOI: 10.1016/j.pbb.2024.173707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Abigail L Brewer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota, Minneapolis, MN, United States of America; Medical Discovery Team on Addiction, University of Mi…. Hauptthemen laut MEDLINE: Cannabinoids, Substance Withdrawal Syndrome, Morpholines, Naphthalenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic cannabinoids are associated with higher risk of dependence and more intense withdrawal symptoms than plant-derived Δ9-tetrahydrocannabinol (THC). Avoidance of withdrawal symptoms, including anxiogenic effects, can contribute to continued cannabinoid use. Adult male and female Long-Evans rats were given escalating doses of WIN 55,212-2 (WIN) via twice daily intrajugular infusions. Precipitated withdrawal was elicited with SR 141716 (rimonabant) 4 h after the final infusion. Global withdrawal scores (GWS) were compiled by summing z-scores of observed somatic behaviors over a 30-min period with locomotor activity simultaneously collected via beam breaks. Rimonabant precipitated withdrawal in female and male rats at 3 or 10 mg/kg, respectively, but the individual behaviors contributing to GWS were not identical. 3 mg/kg rimonabant did not impact locomotor behavior in females, but 10 mg/kg decreased locomotion in male controls. Spontaneous withdrawal observed between 6 and 96 h after the final infusion was quantifiable up to 24 h following WIN administration. Individual behaviors contributing to GWS varied by sex and time point. Males undergoing spontaneous withdrawal engaged in more locomotion than females undergoing withdrawal. Separate groups of rats were subjected to a battery of anxiety-like behavioral tests (elevated plus maze, open field test, and marble burying test) one or two weeks after WIN or vehicle infusions. At one week abstinence, sex-related effects were noted in marble burying and the open field test but were unrelated to drug treatment. At two weeks abstinence, females undergoing withdrawal spent more time grooming during marble burying and performed more marble manipulations than their male counterparts. WIN infusions did not impact estrous cycling, and GWS scores were not correlated with estrous at withdrawal. Collectively, these results show qualitative sex differences in behaviors contributing to the behavioral experience of cannabinoid withdrawal supporting clinical findings from THC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsSubstance Withdrawal SyndromeMorpholinesNaphthalenesBenzoxazinesRatsFemaleAnimalsMaleCannabinoid Receptor AgonistsRimonabantDronabinolPiperidinesPyrazolesRats, Long-EvansAnxietyCalcium Carbonate

Stichwörter der Autor:innen

Anxiety-like behaviorsCannabinoid withdrawalRodent models of withdrawalSex differencesSynthetic cannabinoid

Substanzen

Cannabinoid Receptor AgonistsRimonabantDronabinol(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanonePiperidinesPyrazolesCannabinoidsCalcium CarbonateMorpholinesNaphthalenes

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota, Minneapolis, MN, United States of America; Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, United States of America. Electronic address…
  • Department of Pharmacology, University of Minnesota, Minneapolis, MN, United States of America; Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, United States of America.

Förderung

  • NIDA NIH HHS

Zitieren

APA

Brewer, A. L., Felter, C. E., Sternitzky, A. R., & Spencer, S. M. (2024). Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173707

Vancouver

Brewer AL, Felter CE, Sternitzky AR, Spencer SM. Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2024.173707

BibTeX
@article{Brewer2024,
  author = {Brewer, Abigail L and Felter, Claire E and Sternitzky, Anna R and Spencer, Sade M},
  title = {Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2024},
  doi = {10.1016/j.pbb.2024.173707}
}
Kostenlos starten →